Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
RESEARCH TOOLSreports
Total Valuation
CAMP4 Therapeutics Corporation has a market cap or net worth of $39.31M. The enterprise value is $49.85M.
Market Cap$39.31M
Enterprise Value$49.85M
Share Statistics
CAMP4 Therapeutics Corporation has 20,161,072 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,161,072
Owned by Insiders79.64%
Owned by Institutions―
Financial Efficiency
CAMP4 Therapeutics Corporation’s return on equity (ROE) is -2.27 and return on invested capital (ROIC) is -8.12%.
Return on Equity (ROE)-2.27
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-8.12%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee5.36M
Profits Per Employee-590.73K
Employee Count55
Asset Turnover0.78
Inventory Turnover7.78
Valuation Ratios
The current PE Ratio of CAMP4 Therapeutics Corporation is -109.12. CAMP4 Therapeutics Corporation’s PEG ratio is -48.01.
PE Ratio-109.12
PS Ratio―
PB Ratio247.81
Price to Fair Value247.81
Price to FCF-104.18
Price to Operating Cash Flow-154.60
PEG Ratio-48.01
Income Statement
In the last 12 months, CAMP4 Therapeutics Corporation had revenue of 294.95M and earned -32.49M in profits. Earnings per share was -0.90.
Revenue294.95M
Gross Profit109.01M
Operating Income-21.48M
Pretax Income-31.34M
Net Income-32.49M
EBITDA276.00K
Earnings Per Share (EPS)-0.90
Cash Flow
In the last 12 months, operating cash flow was 4.90M and capital expenditures -7.98M, giving a free cash flow of -3.08M billion.
Operating Cash Flow4.90M
Free Cash Flow-3.08M
Free Cash Flow per Share-0.15
Dividends & Yields
CAMP4 Therapeutics Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change-79.69%
50-Day Moving Average4.05
200-Day Moving Average―
Relative Strength Index (RSI)30.72
Average Volume (3m)37.61K
Important Dates
CAMP4 Therapeutics Corporation upcoming earnings date is Mar 27, 2025, TBA Not Confirmed.
Last Earnings DateNov 21, 2024
Next Earnings DateMar 27, 2025
Ex-Dividend Date―
Financial Position
CAMP4 Therapeutics Corporation as a current ratio of 1.64, with Debt / Equity ratio of 1680.54%
Current Ratio1.64
Quick Ratio1.42
Debt to Market Cap0.07
Net Debt to EBITDA719.23
Interest Coverage Ratio-3.43
Taxes
In the past 12 months, CAMP4 Therapeutics Corporation has paid 1.15M in taxes.
Income Tax1.15M
Effective Tax Rate-0.04
Enterprise Valuation
CAMP4 Therapeutics Corporation EV to EBITDA ratio is 13.56K, with an EV/FCF ratio of -110.01.
EV to Sales12.69
EV to EBITDA13.56K
EV to Free Cash Flow-110.01
EV to Operating Cash Flow-163.26
Balance Sheet
CAMP4 Therapeutics Corporation has $38.17M in cash and marketable securities with $10.07M in debt, giving a net cash position of $203.74M billion.
Cash & Marketable Securities$38.17M
Total Debt$10.07M
Net Cash$203.74M
Net Cash Per Share$10.11
Tangible Book Value Per Share-$2.95
Margins
Gross margin is 35.97%, with operating margin of -7.28%, and net profit margin of -11.02%.
Gross Margin35.97%
Operating Margin-7.28%
Pretax Margin-10.63%
Net Profit Margin-11.02%
EBITDA Margin0.09%
EBIT Margin0.00%
Analyst Forecast
The average price target for CAMP4 Therapeutics Corporation is $17.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$17.50
Price Target Upside797.44% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―